美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GSK plc ADRhedged

69.80

+2.834.23%

盤後：69.900.0975+0.14%16:10 EDT

成交量：858

成交額：5.98萬

市值：69.81萬

市盈率：- -

高：70.05

開：69.80

低：69.34

收：66.97

52周最高：85.03

52周最低：55.75

股本：1.00萬

流通股本：1.00萬

量比：4.75

換手率：8.58%

股息：2.08

股息率：2.97%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

GLP-1為王、專利懸崖逼近、新賽道搶跑跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組

每日经济新闻

阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大

據英國金融時報報道英國製藥商阿斯利康一直在探索與美國競爭對手百時美施貴寶合併的交易合併後將打造全球最大的製藥集團之一市值

GSK上半年核心營業利潤增長管線優化同步推進

经济参考网

美股異動 | 醫藥板塊走強葛蘭素史克(GSK.US)績後大升逾7%

美股異動｜醫藥股板塊普漲，葛蘭素史克漲近7%，安進升逾5%，艾伯維公司漲近4%，輝瑞、默沙東升逾3%

老虎资讯综合

美股開盤 | 三大指數升跌不一，康寧跌超14%，葛蘭素史克升逾4%，可口可樂升逾3%

老虎资讯综合

葛蘭素史克首席執行官：媒體電話會議發言稱，我們認為公司現有營收與收益流規模充足，足以抵消艾滋病藥物專利失效帶來的損失。

葛蘭素史克首席執行官就劍橋投資表示，我們並未尋求英國政府支持。

葛蘭素史克擬在英國劍橋生物醫學園區建立新旗艦研發中心

葛蘭素史克美股盤前升逾5%

葛蘭素史克：未來三年內向英國投資4億英鎊

葛蘭素史克在倫敦上漲2.5%

每日经济新闻

葛蘭素史克股價上漲2.5%，觸及盤中高點，此前該公司公布的盈利報告超出預期。

葛蘭素史克表示其目標是到2029年全面實現每年19億英鎊的成本節約。

葛蘭素史克Q2調整後EPS為50.5便士超預期

盤前異動 | 存儲、半導體板塊集體下挫，西部數據、美光跌超5%，海力士跌超4%、英特爾、AMD跌超4%

老虎资讯综合

GSK憑藉Jideytro獲得美國食品藥品監督管理局（FDA）的早期批准，正式進軍肺癌藥物市場

創新藥研發加速遇「猴荒」

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GSKH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.8025,"timestamp":1789416000000,"preClose":66.9705,"halted":0,"volume":858,"hourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"delay":0,"changeRate":0.042287275740811155,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"未開盤","change":2.832,"latestTime":"09-14 16:00:00 EDT","open":69.8,"high":70.05,"low":69.34,"amount":59772,"amplitude":0.010602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":66.9705,"nav":66.979706,"aum":669864.039706,"dividendRate":0.029742,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"volumeRatio":4.745573,"impliedVol":0.1896,"impliedVolPercentile":0.4649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.745573,"shares":10001,"dividePrice":2.0761,"high":70.05,"amplitude":0.010602,"preClose":66.9705,"low":69.34,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.8025,"eps":0,"divideRate":0.029742,"volume":858,"delay":0,"ttmEps":0,"open":69.8,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":69.5112,"twentyDayClose":68.9018,"sixtyDayClose":73.2027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658535936","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑 跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535936","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535936?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363243,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836820982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836820982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PJP","FXH","PPH","RSPH","BK4144","GLP","FHLC","BME","GSKH","TRUH","MEDI","JDOC","BBH","APXH","IHE","BK4590","TMED","BBP","PBPH","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641919","title":"GLP-1為王、專利懸崖逼近、新賽道搶跑：跨國藥企2026上半年業績背後的版圖重組","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641919","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641919?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:49","pubTimestamp":1786110543,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835488463.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835488463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BBP","BBH","TRUH","GSKH","FHLC","FXH","BK4590","BK4144","PJP","PPH","IYH","PBPH","IHE","GLP","TMED","JDOC","RSPH","APXH","MEDI","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["AZN","AZNH","LU1032466523.USD","LU0868494617.USD","LU2596442595.SGD","LU0432979614.USD","BMY","PJP","LU1585245621.USD","RSPH","JDOC","PBPH","LU1670711123.USD","LU0225284248.USD","APXH","LU0321505868.SGD","IHE","LU0985481810.HKD","TRUH","FTXH","AZ","LU0882574055.USD","PPH","LU0267386448.USD","LU1868837300.USD","LU1093756168.USD","LU2089984988.USD","BK4588","LU0128525929.USD","TMED","LU2462157665.USD","LU1868836591.USD","IYH","LU2237443382.USD","BK4559","LU0321505439.SGD","BBP","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1868836914.USD","BBH","MEDI","FHLC","LU1670710588.SGD","LU2237443895.HKD","GSKH","LU2242646821.SGD","LU1093756325.SGD","FXH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656493343","title":"據英國金融時報報道英國製藥商阿斯利康一直在探索與美國競爭對手百時美施貴寶合併的交易合併後將打造全球最大的製藥集團之一市值","url":"https://stock-news.laohu8.com/highlight/detail?id=2656493343","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656493343?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 03:22","pubTimestamp":1785698576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","IHE","LU0708994859.HKD","LU2237443549.SGD","FTXH","LU0225771236.USD","LU2237443895.HKD","LU2125154778.USD","LU0109394709.USD","LU0868494617.USD","LU1670711123.USD","BK4588","LU1267930573.SGD","LU1261432733.SGD","LU2237443622.USD","LU0306806265.USD","BMY","LU0061475181.USD","LU1093756168.USD","LU2417539215.USD","LU0889565916.HKD","LU1989771016.USD","LU0289739699.SGD","LU2125154935.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU1868837136.USD","IE00B3T34201.USD","LU0456855351.SGD","LU2456880835.USD","IE0009355771.USD","LU1868836757.USD","GSKH","AZNH","LU2237443978.SGD","BK4534","LU2133065610.SGD","LU1868837300.USD","LU1323610961.USD","AZN","BK4559","BK4007","LU2236285917.USD","LU0114720955.EUR","LU1571399168.USD","LU0321505868.SGD","LU2360032135.SGD","IE00B2B36J28.USD","LU0321505439.SGD","LU1032466523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655336136","title":"GSK上半年核心營業利潤增長 管線優化同步推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2655336136","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655336136?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 21:00","pubTimestamp":1785502815,"startTime":"0","endTime":"0","summary":"7月28日，葛兰素史克（GSK）公布2026年第二季度及上半年业绩。财报显示，今年上半年，葛兰素史克实现总营收160.38亿英镑，同比增长5%（以固定汇率计价，下同）；受期内药物临床试验失败等因素影响，公司总营业利润为27.74亿英镑，同比减少31%。不过，公司核心营业利润（剔除非经常性项目后的“常态化”利润）为54.50亿英镑，同比增长8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607313828578150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607313828578150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1829250122.USD","GSKH","BK4532","GSK.UK","BK4007","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888584","title":"美股異動 | 醫藥板塊走強 葛蘭素史克(GSK.US)績後大升逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654888584?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 22:50","pubTimestamp":1785250222,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSK.UK","LU1829250122.USD","BK4532","GSK","BK4007","GSKH","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117275596","title":"美股異動｜醫藥股板塊普漲，葛蘭素史克漲近7%，安進升逾5%，艾伯維公司漲近4%，輝瑞、默沙東升逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117275596","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117275596?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 22:29","pubTimestamp":1785248946,"startTime":"0","endTime":"0","summary":"7月28日，医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%，强生涨近3%，礼来涨超2%。消息面上，葛兰素史克公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","ABBV","LLYZ","GSKH","AMGN","LLII","MRK","PFE","GSK","JNJ","LLY","LLYX","ELIL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1134607161","title":"美股開盤 | 三大指數升跌不一，康寧跌超14%，葛蘭素史克升逾4%，可口可樂升逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134607161","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134607161?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 21:31","pubTimestamp":1785245499,"startTime":"0","endTime":"0","summary":"7月28日，美股三大指数开盘涨跌不一，道指涨0.66%，纳指跌0.61%，标普500跌0.14%。康宁跌超14%，Q2营收利润双超预期，但Q3收入指引不够“惊喜”；葛兰素史克涨超4%，可口可乐涨超3%，波音、PayPal涨近1%。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BA","SPY","SPYU","CNAV","SDOW","BK4588","GSKH","RAM","GSK","GLWG","UDN","LU1861220033.SGD","PTF","LU1861215975.USD","SMAX","UUP","LU0963586101.USD","DDM","DRAM","SDS","SPUU","SH","DXD","YSPY","GLW","DIA","SPYQ","LU0054578231.USD","UDOW","BOEU","SPYM","MMAX","SPDN","SPXU","DOG","DMAX","LU2360107168.USD","PYPG","IVV","HIBL","LU2290526834.HKD","SPXS","SPYH","PYPY","KO","VOO",".IXIC",".DJI","BOEG","PYPL","BOED",".SPX","UPRO","SSO","BK4170","SPXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001756","title":"葛蘭素史克首席執行官：媒體電話會議發言稱，我們認為公司現有營收與收益流規模充足，足以抵消艾滋病藥物專利失效帶來的損失。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001756?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 20:03","pubTimestamp":1785240196,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSK.UK","LU1829250122.USD","BK4007","GSKH","BK4532","BK4588","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016400","title":"葛蘭素史克首席執行官就劍橋投資表示，我們並未尋求英國政府支持。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016400?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:52","pubTimestamp":1785239557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1829250122.USD","BK4585","GSK.UK","GSK","BK4588","BK4532","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009999","title":"葛蘭素史克擬在英國劍橋生物醫學園區建立新旗艦研發中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654009999?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:26","pubTimestamp":1785238009,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSKH","GSK.UK","GSK","BK4007","LU1829250122.USD","BK4532","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654695009","title":"葛蘭素史克美股盤前升逾5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654695009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654695009?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:23","pubTimestamp":1785237809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1829250122.USD","BK4585","GSK.UK","GSK","BK4588","BK4532","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300952","title":"葛蘭素史克：未來三年內向英國投資4億英鎊","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300952","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654300952?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:21","pubTimestamp":1785237674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4532","GSKH","GSK.UK","LU1829250122.USD","BK4007","BK4585","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654853009","title":"葛蘭素史克在倫敦上漲2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654853009","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654853009?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:12","pubTimestamp":1785237141,"startTime":"0","endTime":"0","summary":"葛兰素史克在伦敦上涨2.5%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823635566.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823635566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4532","GSK.UK","BK4588","GSKH","LU1829250122.USD","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654800605","title":"葛蘭素史克股價上漲2.5%，觸及盤中高點，此前該公司公布的盈利報告超出預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654800605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654800605?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:09","pubTimestamp":1785236998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4585","LU1829250122.USD","GSK","BK4588","GSKH","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654900642","title":"葛蘭素史克表示其目標是到2029年全面實現每年19億英鎊的成本節約。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654900642","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654900642?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:04","pubTimestamp":1785236671,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","GSK.UK","BK4588","GSKH","GSK","LU1829250122.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006157","title":"葛蘭素史克Q2調整後EPS為50.5便士 超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006157","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 19:03","pubTimestamp":1785236596,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","BK4585","GSK","BK4532","GSKH","GSK.UK","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174181337","title":"盤前異動 | 存儲、半導體板塊集體下挫，西部數據、美光跌超5%，海力士跌超4%、英特爾、AMD跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181337","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174181337?lang=zh_tw&edition=fundamental","pubTime":"2026-07-28 16:03","pubTimestamp":1785225827,"startTime":"0","endTime":"0","summary":"7月28日，美股盘前三大股指期货涨跌不一，道指期货升0.14%，标普500指数期货跌0.18%，纳指期货跌0.89%。存储概念股集体下挫，西部数据、闪迪、美光跌超5%，希捷科技跌超4%，SK海力士跌近4%；光通信概念股普跌，康宁跌超3%，CRDO跌超2%；半导体板块集体下跌，英特尔、AMD跌超4%，阿斯麦跌超3%；热门中概股盘前涨跌不一，网易涨近2%，金山云跌近2%，腾讯音乐跌超1%，小鹏集团跌近1%；","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUZ","SNDU","TME","AMDD","ASMU","SK","SNDG","STX","INTW","AMDW","MUD","CRDU","ASMG","GSKH","MU","SNDC","SNDK","XPEV","WDCX","GSK","MIC","ASML","SKHX","DAMD","PYPG","KO","BA","AMD","MUU","AMDL","AMDG","GLW","AMDU","INTC","KC","SNDQ","PYPL","LINT","HYNX","AMUU","BOEG","GLWG","07709","PYPY","SKHY","SKUU","MUYY","SNXX","XPEG","AMYY","WDC","BOED","SKDD","SKHU","MULL","NTES","SKHZ","BOEU","CRDO","AMDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653767521","title":"GSK憑藉Jideytro獲得美國食品藥品監督管理局（FDA）的早期批准，正式進軍肺癌藥物市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2653767521","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653767521?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 02:12","pubTimestamp":1784743973,"startTime":"0","endTime":"0","summary":"更新 2-GSK凭借Jideytro获得美国食品药品监督管理局的早期批准，正式进军肺癌药物市场重写第1至4段，补充有关药品审批及近期交易的细节Padmanabhan Ananthan/Bhanvi Satija路透7月22日-葛兰素史克GSK.L周三表示，美国食品药品监督管理局已批准其用于治疗某种肺癌的药物。此次批准标志着GSK正式进军利润丰厚的肺癌治疗市场，且批准时间早于FDA设定的9月18日目标行动日期。预计美国食品药品监督管理局将于11月前就Nuvalent的第二款肺癌药物neladalkib作出审批决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1YH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","GSKH","BK4532","GSK","GSK.UK","LU1829250122.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"創新藥研發加速遇「猴荒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["WRND","BIOY","BK4585","GSKH","BBP","BK4588","IBB","GDOC","SBIO","LFSC","PBE","XLVI","APXH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":95,"code":"91000000","status":"200"}]}}